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Abstract
Peritoneal mesothelioma is a rare diagnosis most often seen in middle-aged men and exceedingly rarely in individuals in their teens and twenties. Diagnosis is often
delayed secondary to nonspecific presenting symptoms and a misconception that there must be a history of asbestos exposure to garner such a diagnosis. Here, we
present the case of a 21 year-old female with a histologically confirmed diagnosis of peritoneal mesothelioma and review the key radiologic and histologic findings
of this rare diagnosis.

Case report

Pathology

A 21 year-old female presented to our Emergency Department
with 3-4 months of abdominal swelling and 1-2 months of upper
abdominal pain with nausea and intermittent non-bloody, non-bilious
vomiting. Her past medical history was noncontributory and she had
no known asbestos exposure. Laboratory work-up including complete
blood count (CBC), complete metabolic panel (CMP), urinalysis (UA),
inhibin B, thyroid function tests, and lipase levels were normal and
HIV testing was negative. Tumor markers including alpha fetoprotein
(AFP), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA199), cancer antigen 125 (CA-125) were also negative. Physical exam was
remarkable only for a distended, non-tender abdomen.

Histologic sections of the cecal mass demonstrated a proliferation
of cells with a variable amount of eosinophilic cytoplasm, round
nuclei and prominent nucleoli, and overlying fibroadipose tissue.
These cells were arranged in papillary structures that coalesced focally
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Of note, the patient had undergone contrast-enhanced CT
abdomen/pelvis four years earlier, which demonstrated striated
nephrograms suggestive of pyelonephritis. There had been significant
increase in abdominal circumference as compared to the prior
abdominopelvic scout radiograph (Figure 1).
Contrast enhanced CT of the abdomen and pelvis demonstrated a
large volume of simple ascites with peritoneal thickening, enhancement,
and nodularity involving the greater omentum (Figure 2). Ascites fluid
had attenuation values measuring up to 18 Hounsefield Units (HU).
Dedicated chest CT was not obtained but the pleura within the lung
bases appeared normal and chest x-ray was unremarkable. Ultrasound
guided paracentesis yielded 2.55L of straw-colored ascites, with
significant symptomatic relief following the procedure. Ascites fluid
demonstrated 661 white blood cells (WBC), 622 red-blood cells (RBC)
with macrophages and reactive cells present (Figures 3 and 4).
Shortly thereafter, laparoscopy was performed and demonstrated
extensive carcinomatosis, multiple small subcentimeter liver masses,
peritoneal studding, and cecal and omental masses. Four liters of nonbloody ascites was aspirated.
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Figure 1. A. Scout lateral abdominopelvic radiograph from CT obtained in 2013. B. Scout
lateral radiograph from CT obtained in 2017 demonstrates inreased abdominal girth and
increased hazy opacity within the abdomen suggestive of interval development of ascites.
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Figure 2. (A) Axial contrast-enhanced CT image at the level of the liver dome demonstrates
subtle nodularity along the hepatic dome (long arrow). (B, C) Coronal and axial contrast
enhanced CT images demonstrate a large amount of ascites (asterisk), subtle nodularity
along the undersurface of the right diaphragm (long arrow), and enhancing omentum (short
arrow).

Figure 3. Low power view (4x) of mesothelial proliferation with complex papillary
architecture and coalescence.

(Figures 3 and 4). There was also focal invasion in the surrounding
soft tissue. Immunostains were performed to characterize the tumor
cells: they were positive for calretinin, CK5/6 and WT1 supporting a
mesothelial origin. MOC31, BerEP4 and p53 were negative, ruling out
adenocarcinoma and serous carcinoma.
Overall the histologic features (presence of focal invasion) and
immunochemical profile supported the diagnosis of malignant
mesothelioma, epithelioid type.

Discussion
Peritoneal mesothelioma is a rare diagnosis, which presents with
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Figure 4. High Power view (20x) of tumor cells with eosinophilic cytoplasm, and round
nuclei with prominent nucleoli.

an array of nonspecific symptoms including abdominal distension,
abdominal discomfort, and malaise [1]. The incidence is approximately
1 in 1,000,000, most of these middle-aged men [1]. This devastating
diagnosis has an average survival of 5 to 12 months [1]. Survival has
been shown to increase to 50-60 months with combined cytoreductive
surgery and intra-peritoneal chemotherapy [2].
To the best of our knowledge, there have only been only a few
reports in the literature of patients in their teens and 20s diagnosed
with this entity [3-8], with this population accounting for less than 5%
of the 300-400 cases of peritoneal mesothelioma reported worldwide
per year [8]. Up to 50% of individuals with this diagnosis have no
known history of asbestos exposure, and this number may be higher
in children and young adults with such a diagnosis [1,8]. Other entities
such as SMV virus 40, radiation exposure, genetics, heavy metals,
chronic inflammation, and non-asbestos fibers have been implicated as
possible etiologic factors [1,8].
There are two distinct histological types of peritoneal mesothelioma
including epithelial, which most often presents with diffuse thickening
of the mesentery and peritoneum and/or multiple small nodules
[5]. The sarcomatoid type most often presents with a mass, while
the biphasic type demonstrates a combination of epitheliod and
sarcomatoid features (5). CT findings are variable and it can be
difficult to distinguish peritoneal mesothelioma from peritoneal
carcinomatosis initially [4]. Findings of peritoneal mesothelioma often
include ascites with Hounsefield units between 6 and 25, nodular or
thickened peritoneum, thickening of the falciform ligament, mesenteric
nodularity, and small or large bowel nodules or masses [9-11]. Small
or large bowel, biliary tract, and ureteral obstruction can also be seen.
[11]. Fewer months of symptoms prior to diagnosis has been found
to be associated with statistically significant prolonged survival [10].
Additionally, CT has been found to be effective as a prognostic tool
for patient selection as well as to monitor response to cytoreductive
therapy and intra-peritoneal chemotherapy [11]. Thus, it is critical that
clinicians, radiologists, and pathologists be aware of this entity and its
imaging findings.
Peritoneal mesothelioma rarely occurs in young individuals.
However, this entity should remain in the differential diagnosis for patient
with unexplained ascites, even in young individuals and those with no
known history of asbestos exposure. Earlier consideration of this diagnosis
would result in a faster diagnosis and initiation of treatment.
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